Johnson & Johnson (JNJ) Gains from Investment Securities (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Gains from Investment Securities data on file, last reported at $54.0 million in Q1 2026.

• Quarterly Gains from Investment Securities rose 80.0% year-over-year to $54.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $186.0 million (down 6.53% YoY) and the FY2025 annual result came in at $162.0 million, down 6.9% from the prior year.
• Gains from Investment Securities declined to $54.0 million in Q1 2026 per JNJ's latest filing, from $63.0 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $111.0 million in Q4 2023, with the low at -$185.0 million in Q1 2023.
• Average Gains from Investment Securities over 5 years is $16.8 million, with a median of $33.0 million recorded in 2025.
• Year-over-year, Gains from Investment Securities tumbled 85.59% in 2024 and jumped 500.0% in 2025.
• Johnson & Johnson's Gains from Investment Securities stood at $59.0 million in 2022, then tumbled by 276.27% to -$104.0 million in 2023, then surged by 169.23% to $72.0 million in 2024, then decreased by 12.5% to $63.0 million in 2025, then slipped by 14.29% to $54.0 million in 2026.
• Business Quant data shows JNJ's Gains from Investment Securities at $54.0 million in Q1 2026, $63.0 million in Q4 2025, and $33.0 million in Q3 2025.